Next Article in Journal
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug Delivery
Previous Article in Journal
Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals 2023, 16, 749
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(9), 1357; https://doi.org/10.3390/ph18091357
Action Date Notes Link
article xml file uploaded 11 September 2025 14:48 CEST Original file -
article xml uploaded. 11 September 2025 14:48 CEST Update https://www.mdpi.com/1424-8247/18/9/1357/xml
article pdf uploaded. 11 September 2025 14:48 CEST Version of Record https://www.mdpi.com/1424-8247/18/9/1357/pdf
article supplementary file uploaded. 11 September 2025 14:48 CEST - https://www.mdpi.com/1424-8247/18/9/1357#supplementary
article html file updated 11 September 2025 14:50 CEST Original file https://www.mdpi.com/1424-8247/18/9/1357/html
Back to TopTop